Cyclooxygenase inhibition as a strategy to ameliorate brain injury

Journal of Neurotrauma

Volumn 19, Issue 1, 2002, Pages 1-15

  Hurley, Sean D ^a   Olschowka, John A ^a   O'Banion, M Kerry ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Edema; Glia; Neurons; Nonsteroidal antiinflammatory drugs (NSAIDS); Prostaglandins; Spinal cord injury; Stroke

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOBARBITAL; PROSTAGLANDIN E2;

ANTIINFLAMMATORY ACTIVITY; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; DRUG INHIBITION; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; INFLAMMATION; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVIEW; TREATMENT OUTCOME; VASCULARIZATION;

EID: 0036163960     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771502753460196     Document Type: Review

References (182)

1. 2 production after traumatic brain injury in humans
2. Pretreatment with alpha tocopherol enhances neurologic recovery after experimental spinal cord compression injury
3. Methylprednisolone and membrane properties of primary cultures of mouse spinal cord
4. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
5. Treatment of acute focal cerebral ischemia with prostacyclin
6. Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord
7. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
8. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: Preliminary report
9. NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes: The involvement of prostaglandin E2
10. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
11. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study
12. Characterization of inducible cyclooxygenase in rat brain
13. Inhibition of prostanoid synthesis protects against neuronal damage induced by focal ischemia in rat brain
14. Efficacy of cyclooxygenase-2-specific inhibitors
15. Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats
16. Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease
17. Temporary focal cerebral ischemia in spontaneously hypertensive rats: The effect of ibuprofen on infarct volume
18. Cyclo-oxygenase-2 messenger RNA induction in focal cerebral ischemia
19. Inflammatory mechanisms in Alzheimer's disease: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists
20. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids
21. 2 and indomethacin vasoreactivity in patients with head injury
22. Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury
23. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors
24. Efficacious experimental stroke treatment with high-dose methylprednisolone
25. Cyclooxygenases-1 and -2 are differentially localized to microglia and endothelium in rat EAE and glioma
26. Effect of indomethacin on edema following single and repetitive cerebral ischemia in the gerbil
27. Polyamine and prostaglandin markers in focal cerebral ischemia
28. Indomethacin-mediated improvement following middle cerebral artery occlusion in cats. Effects of anesthesia
29. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence
30. 2 levels in rats
31. Vasoactive prostanoids and traumatic brain injury
32. 2
33. Postischemic hypothermia and IL-10 treatment provide longlasting neuroprotection of CA1 hippocampus following transient global ischemia in rats
34. Experimental cerebral ischemia produced by extracranial vascular injury: Protection with indomethacin and prostacyclin
35. Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats
36. Cyclooxygenase products of arachidonic acid metabolism in cat cerebral cortex after experimental concussive brain injury
37. 1α, and 12-HETE levels following experimental concussive brain injury
38. 2 induces interleukin-6 synthesis in human astrocytoma cells
39. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
40. Human glutathione dependent prostaglandin E synthase: Gene structure and regulation
41. 2 synthesis
42. Indomethacin prevents impaired perfusion of the dogs's brain after global ischemia
43. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation
44. Effect of dexamethasone, indomethacin, ibuprofen, and probenecid on carrageenan-induced brain inflammation
45. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer
46. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
47. Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation
48. Inducible cyclooxygenase may have anti-inflammatory properties
49. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids
50. Cyclooxygenase-2 in the spinal cord: Localization and regulation after a peripheral inflammatory stimulus
51. Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction
52. Spinal cord injury in the rat: Treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function
53. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398
54. High-dose glucocorticoid treatment improves neurological recovery in head-injured mice
55. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury
56. Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog
57. Prostaglandin I2, indomethacin, and heparin promote postischemic neuronal recovery in dogs
58. Prostaglandin profiles in relation to local circulatory changes following focal cerebral ischemia in cats
59. Peroxisome proliferator-activated receptor-g ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo
60. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
61. Leukocyte traffic in the central nervous system: The participants and their roles
62. 2 in a murine model of inflammation: Possible role of cyclooxygenase-2
63. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system
64. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
65. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury
66. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia
67. Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia
68. Negative feedback between prostaglandin and α- and β-chemokine synthesis in human microglial cells and astrocytes
69. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension
70. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
71. Effect of indomethacin and a free radical scavenger on cerebral blood flow and edema after cerebral artery occlusion in cats
72. Altered levels of PGF in cat spinal cord tissue following traumatic injury
73. Cyclo-oxygenase inhibition by indomethacin and recirculation following cerebral ischemia
74. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
75. Effect of indomethacin pretreatment on acute mortality in experimental brain injury
76. High-dose methylprednisolone therapy reduces expression of JE/MCP-1 mRNA and macrophage accumulation in the ischemic rat brain
77. Induction of cyclooxygenase-2 messenger RNA after transient and permanent middle cerebral artery occlusion in rats: Comparison with c-fos messenger RNA by using in situ hybridization
78. Indomethacin, prostacyclin, and heparin improve postischemic cerebral blood flow without affecting early postischemic granulocyte accumulation
79. Spreading depression-induced cyclooxygenase-2 expression in the cortex
80. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids
81. 2 formation but does not alter brain edema or clinical recovery after closed head injury in rats
82. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
83. Role of eicosanoids, nitric oxide, and afferent neurons in antacid-induced protection in the rat stomach
84. Pain management in osteoarthritis: The role of COX-2 inhibitors
85. Leukocyte migration in immune complex glomerulonephritis: Role of adhesion receptors
86. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
87. Eicosanoids in the central nervous system
88. Outcome of specific COX-2 inhibition in rheumatoid arthritis
89. Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats
90. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages
91. Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic
92. 2 in lipopolysaccharide-stimulated rat peritoneal macrophages
93. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase)
94. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production
95. 2
96. 2 and LTC4 in experimental spinal cord injuries
97. Cerebral oedema and blood-brain and blood-CSF barriers in experimental brain trauma: Effect of indomethacin - A prostaglandin synthetase inhibitor
98. 2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
99. Lipid alterations following impact spinal cord injury in the rat
100. Prostanoid receptors. Structure, function, and distribution
101. Prostanoid receptors: Structures, properties, and functions
102. Effect of MCI-186 on brain edema in rats
103. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage
104. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia
105. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein
106. cDNA cloning and functional activity of a glucocorticoidregulated inflammatory cyclooxygenase
107. Interleukin-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures
108. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology
109. Localization and distribution of cyclooxygenase-2 in brain tissue by immunohistochemistry
110. Selective inhibition of cyclooxygenase-2 attenuates expression of inflammation-related genes in CNS injury
111. Induction of cyclooxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: Specific localization in affected neurones and axons
112. The early induction of cyclooxygenase 2 associated with neurofibrillary degeneration in brains of patients with Fukuyamatype congenital muscular dystrophy
113. ICAM-1 induction in the mouse CNS following irradiation
114. Release of endogenous neurochemicals may increase vascular permeability, induce edema and influence cell changes in trauma to the spinal cord
115. Effects of indomethacin and ibuprofen on cerebral metabolism and blood flow in traumatized brain
116. Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats
117. Role of prostaglandins in gastroprotection
118. Prostaglandin-induced effects in the primate cerebral circulation
119. Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain
120. Induction of cyclooxygenase-2 in the rat brain after a mild episode of focal ischemia without tissue inflammation or neural cell damage
121. Prostacyclin reduces early ischemic changes in central nervous system
122. Prostacyclin attenuates in the rabbit hippocampus early consequences of transient complete cerebral ischemia
123. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
124. Nitric oxide-based possibilities for pharmacotherapy
125. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo
126. Role of cyclooxygenase 2 in acute spinal cord injury
127. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
128. Effect of clonidine on experimental brain edema in the rat
129. Whole body metabolic responses to brain trauma in the rat
130. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkB kinase
131. Cyclooxygenase-2 is induced globally in infarcted human brain
132. Biosynthesis of PGD2 and TXB2 by rabbit blood monocytes
133. Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2, and c-Fos in the rat brain after transient focal ischemia or kainic acid
134. Effects of methylprednisolone and the combination of α-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue
135. Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: Implication in Alzheimer's disease
136. Persistent accumulation of cyclooxygenase-1 (COX-1)-expressing microglia/macrophages and upregulation by endothelium following spinal cord injury
137. Selective accumulation of cyclooxygenase-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia
138. Indomethacin for brain edema following stroke
139. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
140. Dexamethasone and indomethacin do not affect brain edema following head injury in rats
141. Early perifocal cell changes and edema in traumatic injury of the spinal cord are reduced by indomethacin, an inhibitor of prostaglandin synthesis. Experimental study in the rat
142. Prostaglandins modulate constitutive isoform of heat shock protein (72 kD) response following trauma to the rat spinal cord
143. Role of neurochemicals in brain edema and cell changes following hyperthermic brain injury in the rat
144. Effects of indomethacin on rCBF during and after focal cerebral ischemia in the cat
145. Postischaemic treatment with the prostacycline analogue TTC-909 reduces ischaemic brain injury
146. Head injury induces increased prostaglandin synthesis in rat brain
147. Prostaglandin and thromboxane biosynthesis
148. The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion
149. Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults
150. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels
151. 2 inhibits multiple steps in the NF-κB signaling pathway
152. Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat
153. Functional plasticity of microglia: A review
154. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis
155. 2 biosynthesis
156. Reduction of spinal cord injury by administration of iloprost, a stable prostacyclin analog
157. Indomethacin attenuates early postischemic vasogenic edema and cerebral injury
158. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans
159. Possible involvement of interleukin-1 in cyclooxygenase-2 induction after spinal cord injury in rats
160. The protective effect of mannitol, vitamin E and glucocorticoid on ischaemic brain injury: Evaluation by chemiluminescence, energy metabolism and water content
161. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
162. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation
163. Cyclooxygenases 1 and 2
164. A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia
165. Induced expression of adhesion molecules following focal brain ischemia
166. Prostaglandin endoperoxide synthase: Why two isoforms?
167. 2. Distinct roles of cyclooxygenase-1 and -2
168. Indomethacin, an inhibitor of prostaglandin synthesis attenuates alteration in spinal cord evoked potentials and edema formation after trauma to the spinal cord: An experimental study in the rat
169. Inducible cyclooxygenase and nitric oxide synthase
170. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
171. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
172. Determination and clinical significance of plasma levels of prostaglandins in patients with acute brain injury
173. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
174. Effects of cyclooxygenase and lipoxygenase inhibitors on cerebral edema induced by freezing lesions in rats
175. Cyclooxygenases in the central nervous system: Implications for treatment of neurological disorders
176. Downregulation of neuronal cyclooxygenase-2 expression in endstage Alzheimer's disease
177. Cyclooxygenase-1 in human Alzheimer and control brain: Quantitative analysis of expression by microglia and CA3 hippocampal neurons
178. Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence
179. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
180. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion
181. 2 in the central nervous system in response to brain injury and circulating lipopolysaccharide
182. Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain